DASA3 Share Price Performance
R$3.38
1.68 (98.82%)
15.5% undervalued intrinsic discount
R$4.00
Fair Value
Price R$3.38
AnalystHighTarget R$4.00
AnalystConsensusTarget R$2.91
AnalystLowTarget R$1.00
Fair ValueR$4.00
Share Pricen/a
Diagnósticos da América S.A. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
DASA3 Community Narratives
AN
Fair Value
·Fair Value R$4 15.5% undervalued intrinsic discount
Premium And Home Care Diagnostics Will Drive A Stronger Long-Term Outlook
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value R$2.91 16.1% overvalued intrinsic discount
Premium Diagnostics Focus And Debt Profile Will Limit Long Term Upside Potential
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value R$1 238.0% overvalued intrinsic discount
Premium And Home Care Expansion Will Eventually Constrain Margins And Pressure Future Earnings
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Premium Diagnostics Focus And Debt Profile Will Limit Long Term Upside Potential
Catalysts About Diagnósticos da América Diagnósticos da América provides diagnostic medicine services and operates hospitals and oncology units in Brazil through different business lines and joint ventures. What are the underlying business or industry changes driving this perspective?Read more
AN
R$2.91
16.1% overvalued intrinsic discount
Fair Value
Profit Margin
11.83%
Future PE
6.39x
Price in 2029
R$4.8
Premium And Home Care Expansion Will Eventually Constrain Margins And Pressure Future Earnings
Catalysts About Diagnósticos da América Diagnósticos da América operates diagnostic medicine, hospitals and oncology services in Brazil, with growing exposure to premium, home care and B2B testing. What are the underlying business or industry changes driving this perspective?Read more
AN
R$1
238.0% overvalued intrinsic discount
Fair Value
Profit Margin
1.16%
Future PE
17.64x
Price in 2029
R$1.65
Premium And Home Care Diagnostics Will Drive A Stronger Long-Term Outlook
Catalysts About Diagnósticos da América Diagnósticos da América provides diagnostic medicine and related health services across Brazil, with a growing focus on premium, home care and B2B solutions. What are the underlying business or industry changes driving this perspective?Read more
AN
R$4
15.5% undervalued intrinsic discount
Fair Value
Profit Margin
1.1%
Future PE
74.04x
Price in 2028
R$6.6
Trending Discussion
Recently Updated Narratives
AN
Premium Diagnostics Focus And Debt Profile Will Limit Long Term Upside Potential
Fair Value: R$2.91 16.1% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Premium And Home Care Expansion Will Eventually Constrain Margins And Pressure Future Earnings
Fair Value: R$1 238.0% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Premium And Home Care Diagnostics Will Drive A Stronger Long-Term Outlook
Fair Value: R$4 15.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Diagnósticos da América S.A. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 12, 2026
- -0.92
- 30.38%
- -10.31%
- 114.6%
About DASA3
- Founded
- 1961
- Employees
- 26255
- CEO
- WebsiteView website
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. The company operates through Hospitals and Oncology; Diagnostics - National Operations; and Diagnostics - International Operations segments. It also offers medical, property and vehicle rental, consultancy, and franchise contracting services. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in São Paulo, Brazil.
